Skip to main content
. 2014 Jan 18;4(3):267–279. doi: 10.7150/thno.7323

Figure 1.

Figure 1

In vitro characterization of the drug-resistant cancer cell lines. (A) Clonogenic survival assay of the drug-resistant and the parental cell lines challenged with drug (10µM of tamoxifen; 250nM paclitaxel; 300nM doxorubicin). (B) Matrigel invasion assays comparing the ability of the drug-resistant cells lines to invade through matrigel to the parental. (C) Quantitative PCR analysis of breast cancer cell lines expressing uPAR normalized to normal human mammary epithelial cells. The cell lines analyzed included representative cell lines of each breast cancer subtype in addition to the drug-resistant variants.